Clinical Trials on Integrated Pulmonary Index in New Zealand
Total 1000 results
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPDNew Zealand
-
Mylan Inc.Theravance BiopharmaCompleted
-
Middlemore Hospital, New ZealandUnknownPulmonary Parenchymal LesionsNew Zealand
-
Waikato HospitalWaikato Hospital Research FundCompletedChronic Obstructive Pulmonary DiseaseNew Zealand
-
University of Auckland, New ZealandTerminatedSmoking Cessation | Chronic Obstructive Pulmonary DiseaseNew Zealand
-
InSilico Medicine Hong Kong LimitedCompletedA Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy SubjectsIdiopathic Pulmonary FibrosisNew Zealand
-
University of OtagoHealth Research Council, New ZealandCompleted
-
Fisher and Paykel HealthcareMedical Research Institute of New Zealand; Alana HealthcareTerminatedChronic Obstructive Pulmonary Disease | COPDUnited States, New Zealand
-
GlaxoSmithKlineCompleted
-
VenitiWithdrawnDeep Vein Thrombosis | Pulmonary EmbolusNew Zealand, Australia
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, New Zealand
-
Arrowhead PharmaceuticalsRecruitingIdiopathic Pulmonary FibrosisDenmark, New Zealand, Spain
-
Mundipharma Research LimitedCompletedChronic Obstructive Pulmonary DiseaseChina, Taiwan, Korea, Republic of, New Zealand, Australia
-
Yale UniversityPeraHealthWithdrawnInpatients Who Generate at Least Two Rothman Index ScoresUnited States
-
Theravance BiopharmaGlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveThailand, New Zealand, United Kingdom
-
Crux BiomedicalCompletedPulmonary EmbolismNew Zealand, Australia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Chile, South Africa, New Zealand
-
Algernon PharmaceuticalsCompletedIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedStudy in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017Chronic Obstructive Pulmonary Disease (COPDUnited States, Australia, New Zealand
-
Biosplice Therapeutics, Inc.WithdrawnIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
The George InstituteActive, not recruitingCardiovascular Diseases | Chronic Obstructive Pulmonary DiseaseAustralia, New Zealand
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand
-
Arrowhead PharmaceuticalsTerminatedCystic Fibrosis, PulmonaryAustralia, New Zealand
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)Spain, Germany, South Africa, Australia, Poland, New Zealand, Netherlands
-
Monash Medical CentreMiddlemore Hospital, New Zealand; Prince of Wales Hospital, Sydney; Auckland... and other collaboratorsUnknownVenous Thrombosis | Pulmonary EmbolismAustralia, New Zealand
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, United States, New Zealand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, Romania, Bulgaria, Germany, Netherlands, New Zealand
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand, United Kingdom
-
Flinders UniversityCompletedChronic Obstructive Pulmonary Disease | DyspneaAustralia, New Zealand
-
McMaster UniversityHeart and Stroke Foundation of OntarioCompletedDeep Vein Thrombosis | Venous Thromboembolism | Pulmonary EmbolismCanada, New Zealand
-
Arrowhead PharmaceuticalsRecruitingChronic Obstructive Pulmonary Disease | AsthmaKorea, Republic of, Australia, New Zealand, Poland, Thailand, Spain
-
Dartmouth-Hitchcock Medical CenterCompletedPediatric Obesity | Health Behavior | Body Mass Index | Self EsteemUnited States
-
Aquinox Pharmaceuticals (Canada) Inc.CompletedCOPDUnited States, New Zealand, Poland, Australia, Denmark, Finland, Hungary, Sweden
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
DeyCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Sweden, New Zealand, Russian Federation, United Kingdom
-
Uptake Medical CorpCompletedEmphysemaAustralia, Ireland, Germany, Austria, New Zealand, United Kingdom
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
EmphycorpCellular Sciences, inc.Completed
-
Epix Pharmaceuticals, Inc.CompletedChronic Obstructive Pulmonary Disease | Pulmonary HypertensionUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Pliant Therapeutics, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States, Belgium, Australia, Netherlands, Canada, Italy, New Zealand
-
Beth Israel Medical CenterJohnson & JohnsonCompletedPulmonary DiseasesUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, China, Germany, New Zealand, Taiwan
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedEmphysema | HIV | Chronic Obstructive Pulmonary Disease (COPD)United States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Columbia UniversityNational Institute of Environmental Health Sciences (NIEHS)CompletedChronic Obstructive Pulmonary DiseaseUnited States